EUVIMEDEUVIMED entdecken
CrossrefInfokarte

New biotechnological procedures in swine reproduction

Tihomir Petrujkic

Veterinarski glasnik · 2002

DOI: 10.2298/vetgl0202111p ↗
AbstractBibliografische Angaben

Abstract

New biotechnological procedures and the use of hormones in swine breeding are aimed at increasing the number of piglets in the litter. In small herds and groups, selected sows with 16 mammary complexes (tits) can yield up to 32 piglets, or porkers, per year per sow. In order to achieve such reproduction results, special, individual stalls for sow deliveries are used, in addition to biotechnological methods, with a warm core and floor heating, phased diet and clean facilities. The ovulation value in swine is determined by their genetic and paragenetic effects, and it is often provoked and increased with injections and preparations for superovulation. However, the results vary, since any administration of hormone injecions can reduce the reproductive cycle, shorten the duration of estrus, or disrupt the work of ovaries and create cystic follicles. The use of follicle-stimulating hormones in quantities up to 1000 IU per animal for the induction and synchronization of estrus has become customary for sows and gilts, as well as the use of prostaglandins, the use of GnRH for increasing ovulation in swine and increasing the number of follicles >4 mm in diameter in the implementation of new biotechnologies in swine breeding, increases the number of ovulations and fertility in swine. In this way, reproduction is raised to the highest possible level, and artificial insemination of sows has 12 separate rules which enable better and more successful artificial insemination of sows.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →